{"slug":"retatrutide-postherpetic","verification":{"valid":true,"entries":2,"head":"065c74471512a61ba0d091f9b8504f6524d82fdce3d14796a20eb8f0a922aa41"},"count":2,"sources":[{"id":"s1","type":"review","url":"https://www.eurekalert.org/news-releases/1069301","title":"GLP-1 RA medications safe and very effective for treating overweight or obesity","quote":"The greatest weight loss was reported in an RCT of retatrutide (12 mg once weekly)... Participants using this medication lost up to 22.1% more of their starting weight after 48 weeks compared with participants taking placebo.","summary":"Summarizes retatrutide weight loss results from RCTs.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:53:01.571Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"a553f62c89a51bc98e3681034eadd1f707bb1a5142a4280e1f86280103c678dd"},{"id":"s2","type":"clinical_trial","url":"https://trials.lilly.com/en-US/trial/620575","title":"A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain (TRIUMPH-7)","quote":"The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight.","summary":"Describes ongoing trial linking retatrutide to back pain via obesity context.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T00:53:01.571Z","link_status":"ok","quote_status":"unverified","prev":"a553f62c89a51bc98e3681034eadd1f707bb1a5142a4280e1f86280103c678dd","hash":"065c74471512a61ba0d091f9b8504f6524d82fdce3d14796a20eb8f0a922aa41"}]}